See All Slides - tctmd.com

Slides

Presentation TCT 2013

Progress with a Fully Drug-Eluting Bioresorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 27, 2013

Presentation TCT 2013

Discussion with Audience Q&A

Presenter: Ariel Sverdlik

October 27, 2013

Presentation TCT 2013

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Management of Patients with Atrial Fibrillation and Stents

Presenter: Neal Kleiman

October 27, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

Presentation TCT 2013

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Presenter: Renu Virmani

October 27, 2013

Presentation TCT 2013

In Hospital Clinical Outcomes

Presenter: Christian Hamm

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Presenter: Mark Hlatky

October 27, 2013

Presentation TCT 2013

Update of Pharmacoinvasive Strategies for STEMI

Presenter: Frans Van de Werf

October 27, 2013

Presentation TCT 2013

Transfemoral (Whenever Possible) is Clearly Superior!

Presenter: Martyn Thomas

October 27, 2013

Advertisement

Slides

Progress with a Fully Drug-Eluting Bioresorbable Scaffold with EPC-Capture Technology

Discussion with Audience Q&A

Coronary Artery Disease: Pathology and Pathogenesis

Management of Patients with Atrial Fibrillation and Stents

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

In Hospital Clinical Outcomes

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Update of Pharmacoinvasive Strategies for STEMI

Transfemoral (Whenever Possible) is Clearly Superior!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content